Close Menu

HIV

UK-based molecular diagnostics developer Lumora has partnered with the Foundation for Innovative New Diagnostics to develop a rapid, high-throughput malaria diagnostic assay to screen patients in the developing world.

Scientists from Seattle's PATH institute, the Fred Hutchinson Cancer Research Center, and Alere subsidiary TwistDx have published a paper demonstrating the rapid detection of HIV-1 proviral DNA using assays based on TwistDx's recombinase polymerase amplification, an isothermal am

NEW YORK (GenomeWeb News) – Alere said today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill and Melinda Gates Foundation to further develop a pair of point-of-care molecular testing platforms.

Health management services and diagnostics firm Alere recently updated investors on the progress of a pair of nucleic acid testing platforms that are currently under development at the company and represent the firm's entrée into molecular diagnostics.

Quidel disclosed this week that it has been awarded a milestone-based grant from the Bill and Melinda Gates Foundation to support the development, validation, and manufacture of a low-cost quantitative nucleic acid test to monitor HIV drug treatment.

Researchers testing a prototype of a Roche next-gen sequencing assay to measure drug resistance in HIV patients recently reported that the test's performance was comparable to Siemen's TruGene assay, which uses real-time PCR and Sanger sequencing and is approved by the US Food an

NEW YORK (GenomeWeb News) – The UK's Medical Research Council has funded a new international initiative seeking to develop a multi-partner platform that will harness genomics and other technologies to study chronic, non-communicable diseases that impact sub-Saharan African.

The primary motivation for PerkinElmer's acquisition of Chinese infectious disease diagnostic firm Shanghai Haoyuan Biotech, announced this week, is to provide the Waltham, Mass.-based firm entrée into the nucleic acid-based blood screening market, company executives said this we

Researchers at Imperial College London have developed a high-sensitivity immunoassay that can be easily read with the naked eye.

Working with a microfluidic system first developed at the University of California, Berkeley, newly formed company Diassess is planning to use a $148,000 Small Business Innovation Research grant from the National Institutes of Health to demonstrate a single-cartridge, self-powere

Pages

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.